Introduction
Reports of unexpected hepatotoxicity of drugs are increasing.1-3 Penicillins, however, are rarely reported as causing liver damage, though transiently increased activities of serum aspartate and alanine transaminases (serum AST and serum ALT; SGOT and SGPT) and aLkaline phosphatase have been recorded.4-' Histologically proved anicteric hepatitis was reportedly induced by carbenicillinl7 and oxacillin,'8 and mild cholestasis occurred after oxacillin"9 and phenoxymethylpenicillin.Y Oral penicillin also reportedly caused a chronic fluctuating cholestatic hepatitis. 21 We report a case in which a second episode of severe cholestasis was shown by the macrophage inhibition factor test to have been caused by inadvertent rechallenge with cloxacillin. Hepatic damage by this drug, which is congeneric to oxacillin and differs from it only slightly, has not been reported before. 
Case report
A 69-year-old woman was admitted to hospital in 1976 with cholestatic jaundice. One month before she had been treated with nitrofurantoin for a urinary tract infection. Pneumonia was then suspected and she was given ampicillin and cloxacillin. Two weeks before admission she had begun to itch, and a few days later jaundice appeared.
On admission she had a normal temperature and showed signs of scratching all over her body. The liver was enlarged 3 cm below the costal margin and had a span of 15 cm. The spleen was not palpable. Haemoglobin concentra-tion was 13 9 g/dl, white cell count 9 x 109/1 (9000/mm3; normal differential), and erythrocyte sedimentation rate (Westergren) 26 mm in the first hour. Serum glucose, blood urea nitrogen, electrolyte, calcium, phosphate, protein, and cholesterol concentrations were normal, as were serum amylase activity and prothrombin time. Total serum bilirubin concentration was 255 ,tmol/l (149 mg/100 ml), direct value 164 Lmol/l (9-6 mg/100 ml); serum AST activity 18 On the 13th hospital day liver needle biopsy showed intrahepatic cholestasis. The abnormal liver function values continued unchanged, and on the 24th day laparotomy was performed. An enlarged, tense liver was seen. An intraoperative cholangiogram was normal. Wedge biopsy of liver showed slight focal fatty changes in the parenchyma and moderate lymphocytic infiltration of portal spaces with a few eosinophils (see figure: top) . There was diffuse moderate to severe cholestasis (figure: bottom). A few scattered small foci of lymphocytes were seen at individual sites of necrosis (figure: top). Occasional slight anisocytosis was observed, some cells having several nuclei. Kupffer cells were swollen and contained lipofuscin and ceroid. No eosinophilic bodies or changes in bile ducts were detected. The diagnosis was a drug-induced hypersensitivity reaction, mainly cholestatic but with minor tissue-cell necrosis.
The patient was discharged 32 days after admission, and over the next two months liver function values returned to normal. Of the three drugs prescribed before admission, only nitrofurantoin was known to cause cholestasis22 23: her condition was therefore attributed to that drug.
A few months after the jaundice had disappeared the patient was given ampicillin for a urinary tract infection. There were no side effects. In April 1978 she presented with an upper respiratory tract infection and was prescribed cloxacillin 2 g daily by mouth. Within four days she began to itch. One week later the total serum bilirubin concentration was 159 ,mol/l (9 3 mg/100 ml), direct value 84 umol/l (4-9 mg/100 ml); serum AST activity 30 Gemsaec units; and alkaline phosphatase activity 676 Gemsaec units. The liver and spleen were not enlarged. A macrophage inhibition factor test confirmed hypersensitivity to cloxacillin. She was followed up as an outpatient, and during the first month the abnormal liver function values continued unchanged. Over the next two months values returned to normal.
Methods and results
The macrophage inhibition factor test was performed by the method of Rajapakse and Glynn24 as modified by Kuritzky et al. 25 Ten elderly patients (three men and seven women) who had taken cloxacillin in the past without adverse effect served as controls. Samples of peripheral blood lymphocytes from the patient and each control were prepared separately and mixed with guinea-pig macrophages (ratio 1:4) in capillary tubes. These were placed in incubation chambers both with appropriate concentrations of cloxacillin and without cloxacillin. After 24 hours of incubation in 5%' CO2 at 370C the area of migration of macrophages in the samples was calculated as the migration index-that is, area of migration with added drug/area of migration without drug. An index of 0 8 or less is taken as positive.
Results in the controls were expressed as a mean.
In the absence of cloxacillin samples from both the patient and the controls showed a migration index of 10. Adding cloxacillin in concentrations of 50, 100, and 200 mg'l1, however, produced indices of 0 68 and 0 96, 0 64 and 0-92, and 0-56 and 0-95 in samples from the patient and controls respectively.
Comment
Recurrent intrahepatic cholestasis rarely occurs as a benign idiopathic disease. Nevertheless, the clinical course and histological changes26 may be similar to those observed in our patient. The benign disease usually begins before the age of 30, though one patient was 59 at onset. 27 The main differential diagnosis is cholestasis induced by drugs. In our patient cloxacillin was not suspected after the first episode of cholestasis, but the subsequent history and clinical and histological findings then suggested cloxacillin as the causative agent. This was confirmed by the macrophage inhibition factor test.
Patients are often prescribed several drugs simultaneously, some of which may be known to cause tissue damage. Thus if tissue damage occurs and is wrongly attributed to such a drug the patient may be inadvertently rechallenged with the toxic agent. We described a similar case28 in which a patient was rechallenged with pyridinolcarbamate after an episode of liver damage that was assumed to have been caused by methyldopa.
The macrophage inhibition factor test is useful for identifying drugs causing hypersensitivity reactions. We therefore suggest that to prevent the risk of rechallenge with hepatotoxic drugs the test should be used in any patient showing signs of liver damage during multiple-drug treatment.
